IGC Pharma (IGC) Depreciation and Depletion (2011 - 2025)
IGC Pharma (IGC) reported Depreciation and Depletion of $105000.0 for Q3 2025, down 27.59% year-over-year from $145000.0 in Q3 2024, and down 17.32% quarter-over-quarter from $127000.0 in Q2 2025.
IGC Pharma (IGC) Depreciation and Depletion (2011 - 2025) Analysis & Trends
IGC Pharma (IGC) has 12 years of Depreciation and Depletion data on file, last reported at $105000.0 in Q3 2025.
- Depreciation and Depletion for Q3 2025 came in at $105000.0, down 27.59% year-over-year; the trailing twelve-month figure through Sep 2025 was $512000.0 (down 10.65% YoY), and the FY2026 annual result was $42000.0, down 92.59% from the prior year.
- Depreciation and Depletion slipped to $105000.0 in Q3 2025 per IGC's latest filing, from $127000.0 in the prior quarter.
- Over five years, Depreciation and Depletion peaked at $200000.0 in Q1 2022 and troughed at -$49000.0 in Q1 2023.
- A 5-year average of $135000.0 and a median of $144000.0 in 2024 frame the typical range for Depreciation and Depletion.
- The sharpest annual moves came in 2023 and 2024: Depreciation and Depletion plunged 124.5% in 2023, then jumped 397.96% in 2024.
- A 5-year view of Depreciation and Depletion shows it stood at $117000.0 in 2021, then surged by 35.04% to $158000.0 in 2022, then decreased by 11.39% to $140000.0 in 2023, then climbed by 2.86% to $144000.0 in 2024, then fell by 27.08% to $105000.0 in 2025.
- Business Quant data shows IGC's Depreciation and Depletion at $105000.0 in Q3 2025, $127000.0 in Q2 2025, and $136000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 1,395.22 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | IGC Pharma | 29.33 Mn | 29.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 105,000.00 |
| Sep 30, 2025 | 105,000.00 |
| Jun 30, 2025 | 127,000.00 |
| Jun 30, 2025 | 127,000.00 |
| Mar 31, 2025 | 136,000.00 |
| Mar 31, 2025 | 136,000.00 |
| Dec 31, 2024 | 144,000.00 |
| Dec 31, 2024 | 144,000.00 |
| Sep 30, 2024 | 145,000.00 |
| Sep 30, 2024 | 145,000.00 |
| Jun 30, 2024 | 142,000.00 |
| Jun 30, 2024 | 142,000.00 |
| Mar 31, 2024 | 146,000.00 |
| Mar 31, 2024 | 146,000.00 |
| Dec 31, 2023 | 140,000.00 |
| Dec 31, 2023 | 140,000.00 |
| Sep 30, 2023 | 140,000.00 |
| Sep 30, 2023 | 140,000.00 |
| Jun 30, 2023 | 137,000.00 |
| Jun 30, 2023 | 137,000.00 |